NCT06993844 2026-03-17Phase 1/2 Study of ETX-636 in Participants With Advanced Solid TumorsEnsem TherapeuticsPhase 1/2 Recruiting233 enrolled
NCT03363893 2025-11-12Modular Study to Evaluate CT7001 Alone in Cancer Patients With Advanced MalignanciesCarrick Therapeutics LimitedPhase 1/2 Completed124 enrolled